Top

Published in:

01-10-2010 | Review

The clinical significance of hyperfiltration in diabetes

Authors: G. Jerums, E. Premaratne, S. Panagiotopoulos, R. J. MacIsaac

Published in: Diabetologia | Issue 10/2010

Abstract

Glomerular filtration rate is commonly elevated in early diabetes and patients with this symptom are arbitrarily considered to have hyperfiltration. The prevalence of hyperfiltration in type 1 diabetes varies from less than 25% to more than 75%. The corresponding figures in type 2 diabetes are significantly lower, ranging between 0% and more than 40%. Several factors, methodological and biological, may contribute to the wide variation in estimates of hyperfiltration prevalence. Methodological differences in measurement and evaluation of GFR apply in particular to the handling of plasma disappearance curves of filtration markers. Biological factors that may influence GFR in the hyperfiltration range include glycaemic control, diabetes duration, BMI, sex, pubertal status in type 1 diabetes and age in type 2 diabetes. Hyperglycaemia may influence GFR and albuminuria, and may therefore confound the evaluation of hyperfiltration as an independent risk factor for diabetic nephropathy. Adequate assessment of the relationship between glycaemic control, GFR and AER therefore requires serial measurements of all three variables followed by multivariate analysis. A recent meta-analysis of ten type 1 diabetes studies concluded that the presence of hyperfiltration at baseline more than doubled the risk of developing micro- or macroalbuminuria at follow-up. However, not all studies allowed for confounding factors or regression dilution bias. Future studies will therefore need to address the independent role of hyperfiltration, not only in the evolution of albuminuria, but also in the subsequent decline of GFR.

Wiseman MJ, Saunders AJ, Keen H, Viberti G (1985) Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617–621CrossRefPubMed

Caramori ML, Gross JL, Pecis M, de Azevedo MJ (1999) Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care 22:1512–1516CrossRefPubMed

Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93CrossRefPubMed

Lervang HH, Jensen S, Brochner-Mortensen J, Ditzel J (1988) Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31:723–729CrossRefPubMed

Brenner BM (1983) Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23:647–655CrossRefPubMed

Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85–F93PubMed

Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–697CrossRefPubMed

Ficociello LH, Perkins BA, Roshan B et al (2009) Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32:889–893CrossRefPubMed

Dahlquist G, Stattin EL, Rudberg S (2001) Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant 16:1382–1386CrossRefPubMed

10.

Zerbini G, Bonfanti R, Meschi F et al (2006) Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 55:2620–2625CrossRefPubMed

11.

Amin R, Turner C, van Aken S et al (2005) The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 68:1740–1749CrossRefPubMed

12.

Chaiken RL, Eckert-Norton M, Bard M et al (1998) Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 21:2129–2134CrossRefPubMed

13.

Brochner-Mortensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271–274CrossRefPubMed

14.

Houlihan C, Jenkins M, Osicka T, Scott A, Parkin D, Jerums G (1999) A comparison of the plasma disappearance of iohexol and ^99mTc-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes. Aust N Z J Med 29:693–700PubMed

15.

Lervang HH, Jensen S, Brochner-Mortensen J, Ditzel J (1992) Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Diabet Med 9:635–640CrossRefPubMed

16.

Chiarelli F, Verrotti A, Morgese G (1995) Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 9:154–158CrossRefPubMed

17.

Azevedo MJ, Gross JL (1991) Follow-up of glomerular hyperfiltration in normoalbuminuric type 1 (insulin-dependent) diabetic patients. Diabetologia 34:611CrossRefPubMed

18.

Mogensen CE, Andersen MJ (1975) Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment. Diabetologia 11:221–224CrossRefPubMed

19.

Wiseman MJ, Viberti GC, Keen H (1984) Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron 38:257–260CrossRefPubMed

20.

Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti G (1987) Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int 31:1012–1018CrossRefPubMed

21.

Schmitz A (1993) Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients—a review. Diabetologia 36:985–992CrossRefPubMed

22.

Damsgaard EM, Mogensen CE (1986) Microalbuminuria in elderly hyperglycaemic patients and controls. Diabet Med 3:430–435CrossRefPubMed

23.

Gragnoli G, Signorini AM, Tanganelli I et al (1993) Prevalence of glomerular hyperfiltration and nephromegaly in normo- and microalbuminuric type 2 diabetic patients. Nephron 65:206–211CrossRefPubMed

24.

Vora JP, Dolben J, Dean JD et al (1992) Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 41:829–835CrossRefPubMed

25.

Silveiro SP, Friedman R, de Azevedo MJ, Canani LH, Gross JL (1996) Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19:171–174CrossRefPubMed

26.

Vedel P, Obel J, Nielsen FS et al (1996) Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 39:1584–1589CrossRefPubMed

27.

Rius F, Pizaro E, Salinas I, Lucas A, Sanmarti A, Romero R (1995) Age as a determinant of glomerular filtration rate in non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant 10:1644–1647PubMed

28.

Premaratne E, MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith T, Jerums G (2005) Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia 48:2486–2493CrossRefPubMed

29.

Myers BD, Nelson RG, Williams GW et al (1991) Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88:524–530CrossRefPubMed

30.

Nelson RG, Bennett PH, Beck GJ et al (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636–1642CrossRefPubMed

31.

Nielsen S, Schmitz A, Rehling M, Mogensen CE (1993) Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes. Diabetes Care 16:1427–1432CrossRefPubMed

32.

Chagnac A, Herman M, Zingerman B et al (2008) Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 23:3946–3952CrossRefPubMed

33.

Tomaszewski M, Charchar FJ, Maric C et al (2007) Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71:816–821CrossRefPubMed

34.

Monami M, Pala L, Bardini G et al (2009) Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study. Acta Diabetol 46:191–196CrossRefPubMed

35.

Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U (2000) Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278:F817–F822PubMed

36.

Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y (2003) The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14:1480–1486CrossRefPubMed

37.

Schmieder RE, Messerli FH, Garavaglia G, Nunez B (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 264:2775–2780CrossRefPubMed

38.

Palatini P, Mormino P, Dorigatti F et al (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70:578–584PubMed

39.

Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE (2005) The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 67:1967–1973CrossRefPubMed

40.

Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE (2000) Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11:1882–1888PubMed

41.

Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82:5963–5967CrossRefPubMed

42.

Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652–659CrossRefPubMed

43.

Vallon V, Richter K, Blantz RC, Thomson S, Osswald H (1999) Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10:2569–2576PubMed

44.

Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V (2001) Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107:217–224CrossRefPubMed

45.

Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF (2005) Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 35:330–336CrossRefPubMed

46.

Sallstrom J, Carlsson PO, Fredholm BB, Larsson E, Persson AE, Palm F (2007) Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 190:253–259CrossRef

47.

Mogensen CE, Andersen MJ (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706–712PubMed

48.

Hostetter TH (2001) Hypertrophy and hyperfunction of the diabetic kidney. J Clin Invest 107:161–162CrossRefPubMed

49.

Bak M, Thomsen K, Christiansen T, Flyvbjerg A (2000) Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 11:1287–1292PubMed

50.

Lawson ML, Sochett EB, Chait PG, Balfe JW, Daneman D (1996) Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM. Diabetes 45:51–55CrossRefPubMed

51.

Walker JD, Bending JJ, Dodds RA et al (1989) Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 2:1411–1415CrossRefPubMed

52.

Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR (1991) Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78–84CrossRefPubMed

53.

Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930CrossRefPubMed

54.

Nenov VD, Taal MW, Sakharova OV, Brenner BM (2000) Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 9:85–97CrossRefPubMed

55.

Taal MW, Brenner BM (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 57:1803–1817CrossRefPubMed

56.

Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH (1995) Low birth weight. A risk factor for development of diabetic nephropathy? Diabetes 44:1405–1407CrossRefPubMed

57.

Chang S, Caramori ML, Moriya R, Mauer M (2008) Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients. Diabetes 57:1707–1711CrossRefPubMed

58.

Rudberg S, Osterby R, Dahlquist G, Nyberg G, Persson B (1997) Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 20:265–271CrossRefPubMed

59.

Berg UB, Torbjornsdotter TB, Jaremko G, Thalme B (1998) Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 41:1047–1056CrossRefPubMed

60.

Drummond K, Mauer M (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51:1580–1587CrossRefPubMed

61.

Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M (2005) The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54:2164–2171CrossRefPubMed

62.

Mogensen CE (1986) Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46:201–206CrossRefPubMed

63.

Rudberg S, Persson B, Dahlquist G (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8-year prospective study. Kidney Int 41:822–828CrossRefPubMed

64.

Nordquist L, Brown R, Fasching A, Persson P, Palm F (2009) Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Renal Physiol 297:F1265–F1272CrossRefPubMed

65.

Bakris GL, Ritz E (2009) The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. Am J Nephrol 30:95–98CrossRefPubMed

66.

Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH (1995) Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47:1726–1731CrossRefPubMed

67.

Mauer M, Zinman B, Gardiner R et al (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361:40–51CrossRefPubMed

68.

Ruggenenti P, Fassi A, Ilieva AP et al (2004) Preventing microalbuminuria in type 2 diabetes. N Engl J Med 351:1941–1951CrossRefPubMed

69.

MacMahon S, Peto R, Cutler J et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765–774CrossRefPubMed

70.

Mogensen CE, Chachati A, Christensen CK et al (1985) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9:85–95PubMed

71.

Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285–2293CrossRefPubMed

72.

Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G (1996) Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 45:1729–1733CrossRefPubMed

73.

Premaratne E, MacIsaac R, Finch S, Panagiotopoulos S, Ekinci E, Jerums G (2008) Serial measurements of cystatin C are more accurate than creatinine-based methods indetecting declining renal function in type 1 diabetes. Diabetes Care 31:971–973CrossRefPubMed

74.

MacIsaac RJ, Tsalamandris C, Thomas MC et al (2006) Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49:1686–1689CrossRefPubMed

75.

MacIsaac RJ, Tsalamandris C, Thomas MC et al (2007) The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med 24:443–448CrossRefPubMed

76.

Perkins BA, Nelson RG, Ostrander BE et al (2005) Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 16:1404–1412CrossRefPubMed

77.

Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819CrossRefPubMed

78.

Costacou T, Orchard TJ (2009) Renal hyperfiltration in relation to low renal function and incidence of overt nephropathy among individuals with type 1 diabetes. Diabetologia 52(Supp. 1):S414

79.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed

80.

Groop P-H, Thomas MC, Moran JL et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658CrossRefPubMed

81.

DCCT/EDIC Research Group, Nathan DM, Zinman B et al (2009) Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 169:1307–1316CrossRefPubMed

82.

Jones SL, Wiseman MJ, Viberti GC (1991) Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 34:59–60CrossRefPubMed

Title: The clinical significance of hyperfiltration in diabetes
Authors: G. Jerums
E. Premaratne
S. Panagiotopoulos
R. J. MacIsaac
Publication date: 01-10-2010
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 10/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1794-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2010

RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity

Identification of undiagnosed type 2 diabetes by systolic blood pressure and waist-to-hip ratio

Beta cell adaptation in pregnancy: a major difference between humans and rodents?

Insulin secretion and impaired glucose tolerance. Reply to Mari A, Ferrannini E [letter]

Intensified glucose lowering in type 2 diabetes: time for a reappraisal

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials